News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
104last 24h
3124last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Simply Wall St.86d agoneutral
Is Vertex Pharmaceuticals (VRTX) Fairly Valued As Pipeline Catalysts Near?Simply Wall St.86d agoneutral
Vertex Pharmaceuticals (VRTX) Could Be 8% Undervalued Following Raised 2026 Guidance24/7 Wall St.87d agoneutral
Inside Latigo Biotherapeutics’ IPO: A Non-Opioid Pain Bet Goes PublicMT Newswires88d agoneutral
Vertex Has Multiple Portfolio Catalysts With Favorable Risk-Reward, RBC SaysInsider Monkey89d agoneutral
One Company’s Clinical Miss Is Another’s Moat: Vertex Rallies as Sionna’s CF Bet CollapsesStockStory89d agoneutral
5 Insightful Analyst Questions From Vertex Pharmaceuticals’s Q2 Earnings CallStocktwits90d agobearish
SION Stock On Track For Worst Day Ever After 90% Drop - What’s Driving The Selloff?BioPharma Dive90d agoneutral
Sionna cystic fibrosis drug fails key trial, removing threat to VertexBarrons.com90d agoneutral
This Biotech’s Drug Could Treat Hot Flashes. The Stock Is Up 32% on Good News.Motley Fool93d agoneutral
Could 1 Tiny Biotech Topple Vertex Pharmaceuticals' Cystic Fibrosis Empire?GuruFocus.com95d agoneutral
AbCellera Biologics Inc (ABCL) (Q2 2026) Earnings Call Highlights: Strong Pipeline Progress and ...MT Newswires96d agoneutral
Vertex Pharmaceuticals Seen Well Positioned Ahead of Pipeline Catalysts, UBS SaysMT Newswires96d agoneutral
Vertex Pharmaceuticals' Solid Q2, Raised Outlook Underscore Core Business Strength, RBC Says